Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dual specificity protein phosphatase 1 (DUSP1), also known as MAP kinase phosphatase-1 (MKP-1), is an enzyme that dephosphorylates both tyrosine and serine/threonine residues on target proteins, particularly MAP kinases (ERKs, JNK, and p38). DUSP1 plays a critical role in regulating cellular responses to environmental stress and inflammation by terminating MAPK signaling cascades involved in cell proliferation, differentiation, apoptosis, and immune responses. It is a key negative regulator of inflammation and mediates the anti-inflammatory effects of glucocorticoids.
Dephosphorylation and inactivation of MAP kinases (ERK, JNK, p38)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dual Specificity Protein Phosphatase 1 (DUSP1).